Related Experiment Videos
Olfactory testing in parkinsonism
1Essex Neuroscience Centre, Oldchurch Hospital, Romford RM7 0BE, UK. chrishawkes@msn.com
The Lancet. Neurology
|June 23, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Validity of model for predicting risk of relapse in MOGAD.
Multiple sclerosis and related disorders·2025
Same author
Mental health as an unmet medical need in NMOSD: how can we do better?
Multiple sclerosis and related disorders·2025
Same author
Is using ChatGPT to help write papers and grants is useful, and ethical?
Multiple sclerosis and related disorders·2023
Same author
Vaccine hesitancy in people with multiple sclerosis.
Multiple sclerosis and related disorders·2022
Same author
EBV as the "gluten of MS" hypothesis provides a rationale for trialing antiviral therapies.
Multiple sclerosis and related disorders·2022
Same journal
Resolution of expression of concern-Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
The Lancet. Neurology·2026
Same journal
UCL Queen Square Institute of Neurology: 75 years of innovation.
The Lancet. Neurology·2026
Same journal
Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.
The Lancet. Neurology·2026